The value of Excess Treatment Costs is not a large sum in the context of overall NHS funding but anecdotal evidence suggests that the (non) payment of Excess Treatment Costs has become a point of friction between providers and commissioners.
Excess Treatment Costs are the difference between the total treatment costs and the cost of standard treatment.
Excess Treatment Costs are part of treatment costs and therefore normal commissioning arrangements apply.
This new guidance on meeting Excess Treatment Costs relates specifically to non-commercial research (i.e. research funded by the NIHR, other areas of central Government including Research Councils, NIHR noncommercial Partners and also Investigator-initiated, commercial-collaborative studies (Industry-funded, non-industry sponsored studies).
It covers the following topics: